hydrogen has been researched along with Fatty Liver, Nonalcoholic in 14 studies
Hydrogen: The first chemical element in the periodic table with atomic symbol H, and atomic number 1. Protium (atomic weight 1) is by far the most common hydrogen isotope. Hydrogen also exists as the stable isotope DEUTERIUM (atomic weight 2) and the radioactive isotope TRITIUM (atomic weight 3). Hydrogen forms into a diatomic molecule at room temperature and appears as a highly flammable colorless and odorless gas.
dihydrogen : An elemental molecule consisting of two hydrogens joined by a single bond.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was aimed to investigate the potential regulatory mechanism of high-content hydrogen water (HHW) in non-alcoholic fatty liver disease (NAFLD)." | 7.88 | High-content hydrogen water-induced downregulation of miR-136 alleviates non-alcoholic fatty liver disease by regulating Nrf2 via targeting MEG3. ( Wang, J; Wang, X, 2018) |
| "Twelve overweight outpatients with NAFLD (age 56." | 6.90 | Hydrogen-rich water reduces liver fat accumulation and improves liver enzyme profiles in patients with non-alcoholic fatty liver disease: a randomized controlled pilot trial. ( Korovljev, D; LeBaron, TW; Ostojic, J; Ostojic, SM; Stajer, V, 2019) |
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| "This study was aimed to investigate the potential regulatory mechanism of high-content hydrogen water (HHW) in non-alcoholic fatty liver disease (NAFLD)." | 3.88 | High-content hydrogen water-induced downregulation of miR-136 alleviates non-alcoholic fatty liver disease by regulating Nrf2 via targeting MEG3. ( Wang, J; Wang, X, 2018) |
| "Twelve overweight outpatients with NAFLD (age 56." | 2.90 | Hydrogen-rich water reduces liver fat accumulation and improves liver enzyme profiles in patients with non-alcoholic fatty liver disease: a randomized controlled pilot trial. ( Korovljev, D; LeBaron, TW; Ostojic, J; Ostojic, SM; Stajer, V, 2019) |
| "Hydrogen therapy is a very promising treatment against several diseases due to its mild attributes, high affinity and inherent biosafety." | 2.72 | Hydrogen treatment: a novel option in liver diseases. ( Duncan, B; Kuang, X; Shi, J, 2021) |
| "Fifty four patients with NAFLD at the stage of steatosis and steatohepatitis at the age of 1860 years were examined." | 1.72 | [The study of abdominal and parietal enteric microbiota in patients with non-alcoholic fatty liver disease]. ( Lukashevich, AP; Lyapina, MV; Vakhrushev, YM, 2022) |
| "Non-alcoholic fatty liver disease (NAFLD) comprises a range of liver diseases, between steatosis and non‑alcoholic steatohepatitis and liver cirrhosis, which are closely associated with diabetes mellitus." | 1.46 | Hydrogen-rich saline improves non‑alcoholic fatty liver disease by alleviating oxidative stress and activating hepatic PPARα and PPARγ. ( Chen, X; Huang, Q; Lu, J; Sun, X; Wang, Q; Zhai, X; Zhang, Y, 2017) |
| "Diet-induced nonalcoholic fatty liver disease (NAFLD) is characterized by profound lipid accumulation and associated with an inflammatory response, oxidative stress and hepatic mitochondrial dysfunction." | 1.43 | Coral calcium hydride prevents hepatic steatosis in high fat diet-induced obese rats: A potent mitochondrial nutrient and phase II enzyme inducer. ( Feng, Z; Hou, C; Liu, J; Long, J; Qiu, Y; Shen, H; Sun, X; Wang, X; Wang, Y; Yan, C; Zhao, L; Zhu, E, 2016) |
| "Children with histologically proven NAFLD, and obese and lean controls received oral fructose (1 g kg(-1) ideal body weight)." | 1.42 | Oral fructose absorption in obese children with non-alcoholic fatty liver disease. ( Johnson, RJ; Le, MT; Love-Osborne, K; Pan, Z; Rivard, C; Robbins, K; Sokol, RJ; Sullivan, JS; Sundaram, SS, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 7 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, H | 1 |
| Bartley, GE | 1 |
| Young, SA | 1 |
| Seo, KH | 1 |
| Yokoyama, W | 1 |
| Tao, G | 1 |
| Zhang, G | 1 |
| Chen, W | 1 |
| Yang, C | 1 |
| Xue, Y | 1 |
| Song, G | 1 |
| Qin, S | 3 |
| Vakhrushev, YM | 1 |
| Lukashevich, AP | 1 |
| Lyapina, MV | 1 |
| Zhao, M | 2 |
| Jin, Z | 1 |
| Xia, C | 1 |
| Chen, S | 1 |
| Zeng, L | 1 |
| He, Q | 1 |
| Sicchieri, JMF | 1 |
| Junqueira, G | 1 |
| Manca, CS | 1 |
| Navarro, AM | 1 |
| de Oliveira, RB | 1 |
| Liu, B | 1 |
| Xue, J | 1 |
| Zhang, M | 1 |
| Wang, M | 1 |
| Ma, T | 1 |
| Gu, Q | 1 |
| Shi, J | 1 |
| Duncan, B | 1 |
| Kuang, X | 1 |
| Wang, X | 2 |
| Wang, J | 1 |
| Korovljev, D | 1 |
| Stajer, V | 1 |
| Ostojic, J | 1 |
| LeBaron, TW | 1 |
| Ostojic, SM | 1 |
| Sullivan, JS | 1 |
| Le, MT | 1 |
| Pan, Z | 1 |
| Rivard, C | 1 |
| Love-Osborne, K | 1 |
| Robbins, K | 1 |
| Johnson, RJ | 1 |
| Sokol, RJ | 1 |
| Sundaram, SS | 1 |
| Hou, C | 1 |
| Wang, Y | 1 |
| Zhu, E | 1 |
| Yan, C | 1 |
| Zhao, L | 1 |
| Qiu, Y | 1 |
| Shen, H | 1 |
| Sun, X | 2 |
| Feng, Z | 1 |
| Liu, J | 1 |
| Long, J | 1 |
| Zhai, X | 1 |
| Chen, X | 1 |
| Lu, J | 1 |
| Zhang, Y | 1 |
| Huang, Q | 1 |
| Wang, Q | 1 |
| Kawai, D | 1 |
| Takaki, A | 1 |
| Nakatsuka, A | 1 |
| Wada, J | 1 |
| Tamaki, N | 1 |
| Yasunaka, T | 1 |
| Koike, K | 1 |
| Tsuzaki, R | 1 |
| Matsumoto, K | 1 |
| Miyake, Y | 1 |
| Shiraha, H | 1 |
| Morita, M | 1 |
| Makino, H | 1 |
| Yamamoto, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Hydrogen-rich Water on Liver Fat Accumulation, Blood Lipids and Body Fatness in Patients With Non-alchoholic Fatty Liver Disease[NCT03625362] | 10 participants (Actual) | Interventional | 2018-09-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for hydrogen and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Hydrogen treatment: a novel option in liver diseases.
Topics: Apoptosis; Humans; Hydrogen; Liver; Liver Neoplasms; Non-alcoholic Fatty Liver Disease | 2021 |
3 trials available for hydrogen and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
A randomized, placebo-controlled clinical trial of hydrogen/oxygen inhalation for non-alcoholic fatty liver disease.
Topics: Animals; Anti-Inflammatory Agents; Diabetes Mellitus, Type 2; Humans; Hydrogen; Liver; Mice; Mice, I | 2022 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Hydrogen-rich water reduces liver fat accumulation and improves liver enzyme profiles in patients with non-alcoholic fatty liver disease: a randomized controlled pilot trial.
Topics: Adipose Tissue; Aged; Body Composition; Cross-Over Studies; Double-Blind Method; Female; Humans; Hyd | 2019 |
10 other studies available for hydrogen and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Altered hepatic gene expression profiles associated with improved fatty liver, insulin resistance, and intestinal permeability after hydroxypropyl methylcellulose (HPMC) supplementation in diet-induced obese mice.
Topics: Animals; Cellulose; Diet, High-Fat; Fatty Liver; Gene Expression Profiling; Gene Expression Regulati | 2013 |
[The study of abdominal and parietal enteric microbiota in patients with non-alcoholic fatty liver disease].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Bacteria; Humans; Hydrogen; Intestine, Small; Lac | 2022 |
Inhibition of free heme-catalyzed Fenton-like reaction prevents non-alcoholic fatty liver disease by hepatocyte-targeted hydrogen delivery.
Topics: Animals; Hepatocytes; Hydrogen; Hydrogen Peroxide; Iron; Liver; Mice; Non-alcoholic Fatty Liver Dise | 2023 |
High intestinal hydrogen production in runners after intake of fructose solution.
Topics: Adult; Female; Fructose; Humans; Hydrogen; Intestines; Male; Non-alcoholic Fatty Liver Disease; Runn | 2020 |
Hydrogen inhalation alleviates nonalcoholic fatty liver disease in metabolic syndrome rats.
Topics: Administration, Inhalation; Animals; Body Mass Index; Diet, Carbohydrate Loading; Diet, High-Fat; Di | 2020 |
High-content hydrogen water-induced downregulation of miR-136 alleviates non-alcoholic fatty liver disease by regulating Nrf2 via targeting MEG3.
Topics: Animals; Cell Line; Cell Survival; Down-Regulation; Hydrogen; Male; Mice; Mice, Inbred C57BL; MicroR | 2018 |
Oral fructose absorption in obese children with non-alcoholic fatty liver disease.
Topics: Adolescent; Biomarkers; Blood Glucose; Body Mass Index; Breath Tests; Child; Eating; Female; Fructos | 2015 |
Coral calcium hydride prevents hepatic steatosis in high fat diet-induced obese rats: A potent mitochondrial nutrient and phase II enzyme inducer.
Topics: Animals; Anthozoa; Body Weight; Calcium Compounds; Dietary Fats; Eating; Enzyme Induction; Glucose; | 2016 |
Hydrogen-rich saline improves non‑alcoholic fatty liver disease by alleviating oxidative stress and activating hepatic PPARα and PPARγ.
Topics: Animals; Biomarkers; Caspase 3; Glucose Tolerance Test; Hydrogen; Insulin Resistance; Male; Non-alco | 2017 |
Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice.
Topics: Animals; Disease Progression; Fatty Liver; Hydrogen; Hypoglycemic Agents; Liver Neoplasms; Male; Mic | 2012 |